ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Family Medicine

Top Family Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARMINE NAZARYAN M.D.

Family Medicine

63,329

$4.66M

950
809 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $57

SAMVEL HMAYAKYAN M.D.

Family Medicine

47,994

$2.69M

831
761 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $57

ARTOON ARAKEL M.D

Family Medicine

46,659

$2.68M

815
772 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $57

GEORGE FIELDS DO

Family Medicine

45,334

$1.51M

1745
1634 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $57

TODD FARRER M.D.

Family Medicine

42,926

$1.92M

1373
1074 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $57

VAGHARSHAK PILOSSYAN M.D.

Family Medicine

41,143

$3.29M

511
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 23%

$80
Average prescription price

Avg: $57

ROBERT WIELENGA M.D.

Family Medicine

40,158

$1.79M

1225
1063 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $57

GARBIS APELIAN MD

Family Medicine

39,642

$3.21M

771
638 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $57

VICTOR LYAPIS M.D.

Family Medicine

39,501

$2.65M

950
883 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $57

JORGE ROBLES MD FAAFP

Family Medicine

38,354

$2.77M

1680
1318 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $57

LILIA WEXLEY M.D

Family Medicine

37,607

$3.71M

515
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 23%

$99
Average prescription price

Avg: $57

HOVANES TER-ZAKARIAN MD

Family Medicine

36,892

$2.92M

512
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $57

ADEL BOUTROS MD

Family Medicine

35,545

$1.84M

993
633 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $57

MANVEL MAZMANYAN M.D.

Family Medicine

34,637

$2.22M

463
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $57

TAYMOUR MALAK M.D.

Family Medicine

33,865

$1.56M

1295
884 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $57

VARDUI ARUTYUNYAN MD

Family Medicine

32,207

$2.23M

551
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $57

ARAM KARAKASHIAN MD

Family Medicine

31,025

$1.68M

617
577 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $57

JAIME ESTRADA MD

Family Medicine

30,981

$1.66M

711
635 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $57

MARY TRAN D.O.

Family Medicine

30,949

$2.33M

767
672 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $57

PAVEL POLSKIY MD

Family Medicine

30,679

$1.65M

1084
898 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $57

JASVIR SIDHU MD

Family Medicine

30,582

$1.47M

1230
860 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $57

ARKADY STERN M.D.

Family Medicine

30,437

$2.99M

516
467 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $57

ELVIS TANSON D.O.

Family Medicine

30,326

$1.69M

1228
495 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

52%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $57

ARKADY MASSEN M.D.

Family Medicine

30,315

$1.71M

836
472 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $57

RODOLFO DAQUIOAG M.D.

Family Medicine

30,222

$1.93M

683
512 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank